Glenview Capital Management - Q4 2017 holdings

$18.5 Billion is the total value of Glenview Capital Management's 58 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 32.1% .

 Value Shares↓ Weighting
HCA SellHCA HEALTHCARE INC$1,084,923,000
-10.1%
12,351,122
-18.5%
5.86%
-16.2%
DWDP SellDOWDUPONT INC$1,063,561,000
-5.4%
14,933,459
-8.0%
5.75%
-11.9%
FMC SellF M C CORP$1,009,869,000
-3.5%
10,668,384
-9.0%
5.46%
-10.1%
SHPG SellSHIRE PLCsponsored adr$890,173,000
-1.0%
5,738,610
-2.2%
4.81%
-7.7%
IQV NewIQVIA HLDGS INC$839,682,0008,576,935
+100.0%
4.54%
FLEX  FLEX LTDord$709,395,000
+8.6%
39,432,7510.0%3.84%
+1.2%
ANTM SellANTHEM INC$687,967,000
-4.7%
3,057,497
-19.6%
3.72%
-11.2%
DXC SellDXC TECHNOLOGY CO$656,972,000
-2.2%
6,922,784
-11.5%
3.55%
-8.9%
TMO BuyTHERMO FISHER SCIENTIFIC INC$631,840,000
+22.4%
3,327,576
+21.9%
3.42%
+14.0%
MCK BuyMCKESSON CORP$592,917,000
+41.9%
3,801,966
+39.7%
3.20%
+32.2%
CI SellCIGNA CORPORATION$531,909,000
-7.7%
2,619,078
-15.1%
2.88%
-14.1%
NWL NewNEWELL BRANDS INC$525,700,00017,012,932
+100.0%
2.84%
GOOGL SellALPHABET INCcap stk cl a$518,012,000
-12.5%
491,752
-19.1%
2.80%
-18.5%
AET SellAETNA INC NEW$517,622,000
-14.2%
2,869,460
-24.4%
2.80%
-20.1%
EBAY BuyEBAY INC$500,775,000
+24.5%
13,269,082
+26.9%
2.71%
+16.0%
WBA BuyWALGREENS BOOTS ALLIANCE INC$495,973,000
+12900.6%
6,829,696
+13725.3%
2.68%
+12086.4%
CVS BuyCVS HEALTH CORP$494,568,000
+344.2%
6,821,631
+398.3%
2.67%
+313.9%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$467,745,000
+83.4%
4,126,555
+79.5%
2.53%
+70.9%
FDC BuyFIRST DATA CORP NEW$459,073,000
+50.0%
27,472,976
+61.9%
2.48%
+39.8%
LH SellLABORATORY CORP AMER HLDGS$425,960,000
-3.0%
2,670,426
-8.2%
2.30%
-9.6%
CBS BuyCBS CORP NEWcl b$399,179,000
+4.8%
6,765,742
+3.0%
2.16%
-2.4%
CAR  AVIS BUDGET GROUP$333,400,000
+15.3%
7,598,0040.0%1.80%
+7.4%
WMB BuyWILLIAMS COS INC DEL$309,455,000
+37.0%
10,149,408
+34.8%
1.67%
+27.6%
THC BuyTENET HEALTHCARE CORP$271,293,000
-7.7%
17,895,314
+0.0%
1.47%
-14.0%
APTV NewAPTIV PLC$249,037,0002,935,720
+100.0%
1.35%
LBTYA SellLIBERTY GLOBAL PLC$246,453,000
-6.3%
6,876,465
-11.4%
1.33%
-12.8%
AAPL SellAPPLE INC$213,503,000
-44.4%
1,261,612
-49.3%
1.15%
-48.2%
LBTYK SellLIBERTY GLOBAL PLC$211,132,000
-1.1%
6,239,140
-4.5%
1.14%
-7.9%
AGN NewALLERGAN PLC$188,866,0001,154,576
+100.0%
1.02%
V SellVISA INC$182,753,000
-14.4%
1,602,813
-21.0%
0.99%
-20.3%
BKD BuyBROOKDALE SR LIVING INC$177,032,000
+6.0%
18,250,718
+15.9%
0.96%
-1.2%
CHTR NewCHARTER COMMUNICATIONS INC Ncl a$160,229,000476,929
+100.0%
0.87%
VER BuyVEREIT INC$159,486,000
+0.8%
20,473,142
+7.3%
0.86%
-6.1%
PNR BuyPENTAIR PLC$157,818,000
+31.1%
2,234,747
+26.2%
0.85%
+22.2%
VNTV BuyVANTIV INCcl a$153,827,000
+1231.8%
2,091,464
+1176.1%
0.83%
+1141.8%
ENDP BuyENDO INTL PLC$149,098,000
+58.9%
19,238,422
+75.6%
0.81%
+48.2%
PAH  PLATFORM SPECIALTY PRODS COR$142,140,000
-11.0%
14,328,6330.0%0.77%
-17.2%
FDX BuyFEDEX CORP$132,038,000
+359.0%
529,127
+314.9%
0.71%
+327.5%
ABBV SellABBVIE INC$131,956,000
-72.2%
1,364,449
-74.5%
0.71%
-74.1%
DNB SellDUN & BRADSTREET CORP DEL NE$130,874,000
-37.9%
1,105,262
-39.0%
0.71%
-42.2%
LOW SellLOWES COS INC$125,593,000
-62.5%
1,351,331
-67.8%
0.68%
-65.1%
DLPH NewDELPHI TECHNOLOGIES PLC$122,078,0002,326,629
+100.0%
0.66%
CCEP SellCOCA COLA EUROPEAN PARTNERS$116,278,000
-11.6%
2,917,898
-7.6%
0.63%
-17.6%
MTOR SellMERITOR INC$114,089,000
-25.4%
4,863,111
-17.2%
0.62%
-30.4%
CMCSA BuyCOMCAST CORP NEWcl a$110,633,000
+24.9%
2,762,360
+20.0%
0.60%
+16.3%
RLGY  REALOGY HLDGS CORP$103,261,000
-19.6%
3,896,6510.0%0.56%
-25.1%
HTZGQ SellHERTZ GLOBAL HLDGS INC$95,193,000
-15.9%
4,307,353
-14.9%
0.52%
-21.6%
MIK NewMICHAELS COS INC$87,975,0003,636,818
+100.0%
0.48%
CNDT BuyCONDUENT INC$82,121,000
+31.0%
5,081,773
+27.0%
0.44%
+22.0%
MHK SellMOHAWK INDS INC$80,715,000
-22.8%
292,551
-30.7%
0.44%
-28.1%
ARMK NewARAMARK$73,304,0001,715,109
+100.0%
0.40%
CAH NewCARDINAL HEALTH INC$46,015,000751,018
+100.0%
0.25%
LYB NewLYONDELLBASELL INDUSTRIES N$43,160,000391,230
+100.0%
0.23%
MON SellMONSANTO CO NEW$37,971,000
-10.9%
325,149
-8.6%
0.20%
-17.0%
KMI  KINDER MORGAN INC DEL$32,881,000
-5.8%
1,819,6300.0%0.18%
-12.3%
KND SellKINDRED HEALTHCARE INC$19,305,000
-32.7%
1,990,247
-52.8%
0.10%
-37.3%
TLRDQ SellTAILORED BRANDS INC$2,893,000
-91.7%
132,517
-94.5%
0.02%
-92.0%
CWSA  CITIGROUP INC*w exp 01/04/201$804,000
-13.1%
8,031,0200.0%0.00%
-20.0%
PX ExitPRAXAIR INC$0-100,000
-100.0%
-0.08%
MGM ExitMGM RESORTS INTERNATIONAL$0-994,046
-100.0%
-0.19%
WYND ExitWYNDHAM WORLDWIDE CORP$0-477,974
-100.0%
-0.29%
TWTR ExitTWITTER INC$0-4,977,679
-100.0%
-0.49%
NKE ExitNIKE INCcl b$0-2,092,657
-100.0%
-0.63%
3106PS ExitDELPHI AUTOMOTIVE PLC$0-2,376,174
-100.0%
-1.36%
ZBH ExitZIMMER BIOMET HLDGS INC$0-3,155,386
-100.0%
-2.14%
Q ExitQUINTILES IMS HOLDINGS INC$0-8,921,356
-100.0%
-4.92%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q4 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings